首页> Clinical and experimental rheumatology> Real-world safety and effectiveness of canakinumab in patients with cryopyrin-associated periodic fever syndrome: a long-term observational study in Japan

Real-world safety and effectiveness of canakinumab in patients with cryopyrin-associated periodic fever syndrome: a long-term observational study in Japan

导出原文传递

翻译打印收藏纠错

第一作者： Hosono, K.

作者： Hosono, K. ^[1] ; Kato, C. ^[2] ; Sasajima, T. ^[3]

作者单位： Patient Safety,Novartis Pharm KK ^[1] Analyt Japan,Novartis Pharm KK ^[2] Med Div,Novartis Pharm KK ^[3]

关键词 canakinumab cryopyrin-associated periodic syndrome familial cold auto-inflammatory syndrome interleukin-1 beta Muckle-Wells syndrome neonatal onset multisystem inflammatory disease observational study rare diseases auto-inflammatory diseases Japan OPEN-LABEL IMMUNOLOGY EFFICACY UPDATE SERIES

发布时间 2023-05-11

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Clinical and experimental rheumatology

2022年40卷8期

1543-1553页

相似文献

中文期刊
外文期刊
学位论文
会议论文

浏览0

点击下载本期目录封面

Clinical and experimental rheumatology

2022年40卷8期

1543-1553页

检索历史清除

Real-world safety and effectiveness of canakinumab in patients with cryopyrin-associated periodic fever syndrome: a long-term observational study in Japan

Clinical and experimental rheumatology

相似文献

同项目论文

Clinical and experimental rheumatology

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Real-world safety and effectiveness of canakinumab in patients with cryopyrin-associated periodic fever syndrome: a long-term observational study in Japan

Clinical and experimental rheumatology

相似文献

同项目论文

Clinical and experimental rheumatology

相关期刊

检索历史清除